Suppr超能文献

长链非编码RNA MALAT1通过拮抗miR-125b抑制膀胱癌细胞凋亡并促进其侵袭。

LncRNA MALAT1 Inhibits Apoptosis and Promotes Invasion by Antagonizing miR-125b in Bladder Cancer Cells.

作者信息

Xie Haibiao, Liao Xinhui, Chen Zhicong, Fang Yuan, He Anbang, Zhong Yucheng, Gao Qunjun, Xiao Huizhong, Li Jianfa, Huang Weiren, Liu Yuchen

机构信息

Key Laboratory of Medical Reprogramming Technology, Department of Urology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen 518039, Guangdong Province, China.

Shantou University Medical College, Shantou 515041, Guangdong Province, China.

出版信息

J Cancer. 2017 Oct 17;8(18):3803-3811. doi: 10.7150/jca.21228. eCollection 2017.

Abstract

Accumulating evidences suggest that longnon-coding RNAs (lncRNAs) play functional roles in development of different cancers, including cancer initiation and progression. Metastasis associated lung adenocarcinoma transcript 1(MALAT1) is a well-known lncRNA which was previously shown to be a direct target of miR-125b in bladder cancer (BCa) and to promote cancer progression and invasion. However, little is known whether MALAT1 can also target miR-125b. In the present study, using CRISPR-based technologies and qRT-PCR, we show that MALAT1 is capable of suppressing mature miR-125b and increasing the expression of its target genes (Bcl-2 and MMP-13), but has no effect on pri-miR-125b and pre-miR-125b. We observe that the biotin-labeled MALAT1-RNA probe is able to pull down Ago2 and miR-125b and that the negative regulation of miR-125b by MALAT1 is dependent on Ago2. Importantly, the results of flow cytometry assay and transwell assay reveal that the MALAT1-mediated cancer progression is in part due to specific suppression of miR-125b and activation of its two target genes. All together, these data suggest that the "MALAT1-miR-125b-Bcl-2 / MMP-13" axis plays an important role in the progression of BCa, thereby may provide a potential therapeutic strategy for the treatment of human BCa.

摘要

越来越多的证据表明,长链非编码RNA(lncRNA)在不同癌症的发展过程中发挥着功能性作用,包括癌症的起始和进展。转移相关的肺腺癌转录本1(MALAT1)是一种著名的lncRNA,先前已证明它是膀胱癌(BCa)中miR-125b的直接靶点,并促进癌症进展和侵袭。然而,关于MALAT1是否也能靶向miR-125b,人们知之甚少。在本研究中,我们使用基于CRISPR的技术和qRT-PCR表明,MALAT1能够抑制成熟miR-125b并增加其靶基因(Bcl-2和MMP-13)的表达,但对pri-miR-125b和pre-miR-125b没有影响。我们观察到生物素标记的MALAT1-RNA探针能够下拉Ago2和miR-125b,并且MALAT1对miR-125b的负调控依赖于Ago2。重要的是,流式细胞术检测和Transwell检测结果表明,MALAT1介导的癌症进展部分归因于对miR-125b的特异性抑制及其两个靶基因的激活。总之,这些数据表明“MALAT1-miR-125b-Bcl-2/MMP-13”轴在BCa进展中起重要作用,从而可能为人类BCa的治疗提供一种潜在的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0158/5688934/82f4bc2f30c9/jcav08p3803g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验